From the Journals

Sleep Apnea’s Billion-Dollar Toll

New analysis links untreated OSA to major productivity losses in working-age adults in the US and UK

Share

  • 1

    Untreated OSA costs the US $180.2 billion and UK £4.22 billion annually.

  • 2

    OSA leads to excessive daytime sleepiness and repeated airway obstructions.

  • 3

    prevalence rates: 22.8% in the US, 19.5% in the UK.

  • 4

    Study included 3,523 US and 840 UK respondents.

  • 5

    Annual productivity loss per affected worker: $3727.40 in the US, £1840 in the UK.

  • 6

    Objective sleep testing is essential for accurate diagnosis.

  • 7

    Symptom-based screening can help identify at-risk individuals.

Original Source(s)

Sleep Apnea’s Billion-Dollar Toll

New analysis links untreated OSA to major productivity losses in working-age adults in the US and UK

  • by Jess Allerton

  • February 25, 2026

  • 2 min

Related Content

Pablo E. Ravenna, M.D., Joins Marcus Neuroscience Institute as a Neuro-ophthalmologist

Neuro-ophthalmologist Pablo E. Ravenna, M.D., has joined Marcus Neuroscience Institute, part of Baptist Health.

  • by

  • February 11, 2026

  • 2 min
COVID Tied to Hidden Smell Deficits

COVID-19 may leave behind unrecognized olfactory deficits linked to cognitive complaints.

Lancet Report: 14 Keys to Dementia Prevention

Lancet Commission identifies 14 modifiable risk factors contributing to 45% of dementia cases.